Head & neck · 2026
Lymphoedema in Head and Neck Cancer Survivors: Healthcare Professionals' Perspectives.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sert Kadriye Yusra, Sundaresan Purnima, Charters Emma, Venchiarutti Rebecca, Sundaram Chindhu Shunmuga, Thorne Melissa, Dhillon Haryana M
Аннотация
INTRODUCTION: Improvements in head and neck cancer (HNC) treatment have increased survival rates, resulting in survivors living with side effects, such as head and neck lymphoedema (HNL). We aimed to document healthcare professionals' perceptions of HNL, approaches to managing HNL, and integration of HNL management into routine practice in Australia and New Zealand.
METHODS: We conducted an online, 51-item survey between February and October 2024. The survey comprised two main sections: (i) all healthcare professionals working with HNC and HNL; and (ii) only HNL therapists.
RESULTS: Participants included in the analysis of the (i) HNC healthcare professionals section (n = 73/113), and (ii) HNL therapists section (n = 40/46). 45% (n = 33/73) of the participants reported not having access to a specialized multidisciplinary team for HNL management. 55% (n = 22/40) of HNL therapists reported not having standardized institutional lymphoedema management protocols.
CONCLUSIONS: Findings highlight the need for system-level guidelines, clearer pathways, improved education resources, and coordinated MDTs to improve HNL management.
METHODS: We conducted an online, 51-item survey between February and October 2024. The survey comprised two main sections: (i) all healthcare professionals working with HNC and HNL; and (ii) only HNL therapists.
RESULTS: Participants included in the analysis of the (i) HNC healthcare professionals section (n = 73/113), and (ii) HNL therapists section (n = 40/46). 45% (n = 33/73) of the participants reported not having access to a specialized multidisciplinary team for HNL management. 55% (n = 22/40) of HNL therapists reported not having standardized institutional lymphoedema management protocols.
CONCLUSIONS: Findings highlight the need for system-level guidelines, clearer pathways, improved education resources, and coordinated MDTs to improve HNL management.